White House lays groundwork to reshore production of 86 essential medicines

The White House Office of Management and Budget is seeking information from pharmaceutical manufacturers to assess US capacity for producing 86 essential generic medicines domestically or near-shore, aiming to reduce reliance on foreign supply chains, particularly China. This effort is part of a national security initiative to strengthen domestic pharmaceutical manufacturing within 18 months.

This Wire brief sits within Fusion42's coverage of Drug Discovery.